UBS Maintains Buy on Cardinal Health, Raises Price Target to $97
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Caliendo maintains a Buy rating on Cardinal Health (NYSE:CAH) and raises the price target from $93 to $97.
June 12, 2023 | 9:14 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Kevin Caliendo maintains a Buy rating on Cardinal Health and raises the price target from $93 to $97.
The raised price target by UBS analyst Kevin Caliendo indicates a positive outlook for Cardinal Health's stock. This news is likely to have a positive impact on the stock price in the short term as it shows increased confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100